Literature DB >> 164203

Cell surface changes correlated with density-dependent growth inhibition. Glycosaminoglycan metabolism in 3T3, SV3T3, and con A selected revertant cells.

R Roblin, S O Albert, N A Gelb, P H Black.   

Abstract

A 35SO4-labeling/chromatography technique has been developed which facilitates quantitation of sulfated glycosaminoglycan (GAG) synthesis in mammalian cell cultures. The technique has been used to compare sulfated GAG biosynthesis, degradation, and turnover in three related cell lines with differing degrees of density-dependent inhibition of growth in vitro (Balb/c 3T3, SV3T3, and SV3T3 revertant cells). Viral transformation of Balb 3T3 cells is accompanied by a 2-5-fold decrease in cell associated sulfated GAG. SV3T3 revertant cells, which show partial reversion to low saturation density in vitro, show a 2.5-8-fold increase in cell-associated sulfated GAG compared to the parental SV3T3 cells from which they were selected. In addition, the distribution of 35SO4 and [3H]glucosamine among the different GAG species produced by SV3T3 revertant cells reverts so that it is similar to the distribution characteristic of untransformed 3T3 cells rather than SV3T3 cells. Mild trypsin treatment of 35SO4-labeled cells removed 68-84% of the cellular sulfated GAG, suggesting that at least this proportion of the total cellular sulfated GAG was located at the cell periphery. Removal of 35SO4-labeled cells from the Petri dish with a Ca2+ selective chelating agent revealed a fraction of the sulfated GAG that remained tightly bound to the Petri dish. A higher proportion of the total cell-associated sulfated GAG remained attached to the Petri dish in cultures of untransformed and revertant cells compared to that present in cultures of transformed cells. A role for sulfated GAG in density-dependent growth inhibition of fibroblast cultures is proposed and discussed in the light of the data obtained.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164203     DOI: 10.1021/bi00673a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Decrease of collagen biosynthesis ability of rat kidney fibroblasts transformed with SV--40 virus.

Authors:  E Bańkowski; W Rzeczycki; H K Nowak; K J Jodczyk
Journal:  Mol Cell Biochem       Date:  1978-06-28       Impact factor: 3.396

2.  Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma.

Authors:  V Bhuvarahamurthy; S Govindasamy
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

3.  Stimulation of endothelial cell growth by myxalin.

Authors:  A Akoum; E Wagner; R Roy
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-09       Impact factor: 2.416

4.  Pulse shape of magnetic fields influences chick embryogenesis.

Authors:  A Ubeda; J Leal; M A Trillo; M A Jimenez; J M Delgado
Journal:  J Anat       Date:  1983-10       Impact factor: 2.610

Review 5.  Human cell transformation by simian virus 40--a review.

Authors:  G H Sack
Journal:  In Vitro       Date:  1981-01

Review 6.  Fibronectin: a review of its structure and biological activity.

Authors:  E Pearlstein; L I Gold; A Garcia-Pardo
Journal:  Mol Cell Biochem       Date:  1980-02-08       Impact factor: 3.396

7.  A comparative study of proteoglycans from bovine lung, trachea, tracheal mucosa, and aorta.

Authors:  P Seethanathan; P Taylor; K Ehrlich
Journal:  Experientia       Date:  1980-03-15

8.  In vitro binding of 67Ga to Ehrlich ascites tumor cells.

Authors:  S Kojima; A Kubodera
Journal:  Eur J Nucl Med       Date:  1984

9.  Serum hyaluronic acid in patients with disseminated neoplasm.

Authors:  G Manley; C Warren
Journal:  J Clin Pathol       Date:  1987-06       Impact factor: 3.411

10.  Incorporation of l-[3H]fucose and d-[3H]glucosamine into cell-surface-associated glycoconjugates in epidermis of cultured pig skin slices.

Authors:  I A King; A Tabiowo; R H Williams
Journal:  Biochem J       Date:  1980-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.